Belhaven Biopharma
Raleigh
About Belhaven Biopharma
Belhaven Biopharma is a clinical trial material scale-up and production, IND preparation and filing, and a pilot human clinical trial for its dry powder intranasal epinephrine for treatment of anaphylaxis
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $21.8M
- Funding stage: Early Stage Venture
- Last round: Series A (Aug 2025)
- Website: belhavenbio.com
Industries & Categories
Biotechnology, Clinical Trials, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/belhaven-biopharma-39056 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.